Just a moment...
Press 'Enter' to add multiple search terms. Rules for Better Search
Use comma for multiple locations.
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
Issues: Whether Modvat credit was admissible on disposable syringes and needles packed with injections when their value was included in the assessable value of the final product and the packing treatment was treated as manufacture under Chapter Note V of Chapter 30.
Analysis: The earlier decisions in the assessee's own case dealt with credit claimed on the footing that the syringes and needles were packing material. In the present matter, the claim rested on a different basis, namely that the goods were cleared along with the injections in a unipack and that the treatment adopted to make the product marketable amounted to manufacture. The Revenue had accepted the value of the syringes and needles by including it in the assessable value of the unipack, and in that situation the same goods could not be excluded from Modvat credit.
Conclusion: Modvat credit on disposable syringes and needles was admissible, and the denial of credit was unsustainable.
Final Conclusion: The appeal succeeded and the assessee obtained relief on the credit entitlement for the disposable syringes and needles.
Ratio Decidendi: Where the value of goods packed with the final product is included in the assessable value and the process is treated as manufacture for excise purposes, credit cannot be denied on the ground that the same goods are not packing material.